Earnings summaries and quarterly performance for NASDAQ.
Executive leadership at NASDAQ.
Adena Friedman
Detailed
Chair and Chief Executive Officer
CEO
Bradley Peterson
Detailed
Executive Vice President and Chief Information Officer/Chief Technology Officer
Bryan Smith
Detailed
Executive Vice President and Chief People Officer
Jeremy Skule
Detailed
Executive Vice President and Chief Strategy Officer; Executive Chair, Financial Crime Management Technology
John Zecca
Detailed
Executive Vice President and Chief Legal, Risk and Regulatory Officer
Michelle Daly
Detailed
Senior Vice President and Controller and Principal Accounting Officer
Nelson Griggs
Detailed
President
Sarah Youngwood
Detailed
Executive Vice President and Chief Financial Officer
Tal Cohen
Detailed
President
Board of directors at NASDAQ.
Alfred Zollar
Detailed
Director
Charlene Begley
Detailed
Director
Essa Kazim
Detailed
Director
Holden Spaht
Detailed
Director
Jeffery Yabuki
Detailed
Director
Johan Torgeby
Detailed
Director
Kathryn Koch
Detailed
Director
Melissa Arnoldi
Detailed
Director
Michael Splinter
Detailed
Lead Independent Director
Thomas Kloet
Detailed
Director
Toni Townes-Whitley
Detailed
Director
Research analysts who have asked questions during NASDAQ earnings calls.
Alexander Blostein
Goldman Sachs
6 questions for NDAQ
Also covers: AB, AMG, AMP +31 more
Ashish Sabadra
RBC Capital Markets
5 questions for NDAQ
Also covers: ADP, CBOE, CLVT +20 more
Benjamin Budish
Barclays PLC
5 questions for NDAQ
Also covers: AB, APO, ARES +23 more
Brian Bedell
Deutsche Bank
5 questions for NDAQ
Also covers: AMG, AMTD, APO +22 more
Michael Cyprys
Morgan Stanley
5 questions for NDAQ
Also covers: AAMI, AMP, AMTD +30 more
Owen Lau
Oppenheimer & Co. Inc.
5 questions for NDAQ
Also covers: CLVT, CME, COIN +8 more
Alex Kramm
UBS Group AG
4 questions for NDAQ
Also covers: BR, CBOE, CBRE +15 more
Patrick Moley
Piper Sandler & Co.
4 questions for NDAQ
Also covers: BGC, CBOE, CME +17 more
Craig Siegenthaler
Bank of America
3 questions for NDAQ
Also covers: AB, AMP, AMTD +26 more
Dan Fannon
Jefferies & Company Inc.
3 questions for NDAQ
Also covers: AB, AMG, AMTD +22 more
Daniel Fannon
Jefferies Financial Group Inc.
3 questions for NDAQ
Also covers: AB, AMG, AMTD +27 more
Jeff Schmitt
William Blair & Company, L.L.C.
3 questions for NDAQ
Also covers: AIZ, AMP, FRGE +8 more
Kyle Voigt
Keefe, Bruyette & Woods
3 questions for NDAQ
Also covers: AMTD, APO, ARES +17 more
Michael Cho
JPMorgan Chase & Co.
3 questions for NDAQ
Also covers: ENV, FHI, FRGE +3 more
Eli Abboud
Bank of America
2 questions for NDAQ
Also covers: BGC, CBOE, CME +2 more
Simon Clinch
Redburn Atlantic
2 questions for NDAQ
Also covers: CME, EFX, FICO +4 more
William Katz
TD Cowen
2 questions for NDAQ
Also covers: AB, AMG, AMTD +25 more
Y. Cho
JPMorgan Chase & Co.
2 questions for NDAQ
Also covers: LPLA
Alexander Kramm
UBS Group AG
1 question for NDAQ
Ben Budish
Barclays PLC
1 question for NDAQ
Also covers: AB, APO, ARES +19 more
Brian Bertram Bedell
Deutsche Bank AG
1 question for NDAQ
Christopher Allen
Citigroup
1 question for NDAQ
Also covers: CBOE, CME, ETOR +9 more
Jeffrey Schmitt
William Blair
1 question for NDAQ
Also covers: AIZ, AMP, CBOE +8 more
Kwun Sum Lau
Oppenheimer
1 question for NDAQ
Also covers: CBOE, CLVT, CME +9 more
Simon Alistair Clinch
Redburn Atlantic
1 question for NDAQ
Also covers: CME, EFX, FICO +3 more
Recent press releases and 8-K filings for NDAQ.
HyOrc positions green methanol as economic solution to shipping decarbonization
NDAQ
Product Launch
New Projects/Investments
- HyOrc’s patented waste-to-fuel platform converts municipal waste into high-purity green methanol with up to a 90% reduction in lifecycle CO₂ emissions, offering a low-CAPEX alternative to e-methanol.
- The closed-loop aqua plasma gasification technology underpins a high-efficiency, low-cost fuel production process, targeting shipping’s decarbonization mandates.
- Through its Portuguese joint venture, HyOrc secured a 10-year offtake agreement with a major European green fuel producer, signaling strong commercial traction.
- HyOrc has 737 million shares outstanding, is fully SEC-reporting, and is preparing for a Nasdaq uplist to enhance market visibility.
22 minutes ago
Faraday Future and FX engage U.S. policy leaders on EV and manufacturing
NDAQ
Product Launch
- FX CEO Max Ma and other executives met with U.S. Congressional members to discuss EV policy, tariffs, U.S. manufacturing, and innovation.
- The company initiated assembly of the FX Super One MPV pre-production vehicles at its Hanford, CA facility, targeting a December 21 ceremony for the first off-line vehicle.
- In 2024, FF launched its Global Automotive Industry Bridge Strategy and introduced the FX brand to localize assembly of world-class vehicle components in the U.S..
- 100% of FF vehicles, including the FF 91 2.0, are built in the U.S., underscoring its robust domestic manufacturing footprint.
7 hours ago
Lifeway criticizes dissident board nominees’ ethics and legal record
NDAQ
Board Change
Proxy Vote Outcomes
Legal Proceedings
- Lifeway accuses Edward Smolyansky and George Sent of ethical failures: Smolyansky’s 2022 termination for cause, intoxication on duty, default on a $4.55 million loan and related foreclosure lawsuit, and alleged negative social media campaigns.
- The company questions George Sent’s judgment, noting his prior role as chair of the special committee that disciplined Smolyansky and his sudden alliance with the dissident group.
- ISS recommended “DO NOT VOTE” on all dissident proposals, criticizing the group’s lack of a compelling case for change and absence of a governance plan.
- Lifeway’s Board has refreshed its composition by appointing four new independent directors under a cooperation agreement with Danone to enhance oversight.
- The Board urges shareholders to reject the dissident’s proxy solicitation to protect shareholder value.
13 hours ago
AlphaTON Capital secures 2.2 MW data center capacity in Sweden
NDAQ
New Projects/Investments
- Under a 60-month agreement starting February 1, 2026, AlphaTON will lease 2,230 kW of peak power at atNorth’s Tier 3 SWE01 facility in Kista, Sweden.
- The contract includes a Right of First Refusal for 2,100 kW more, potentially expanding capacity to 4,330 kW.
- Provides access to sustainable Nordic power with Power Usage Effectiveness capped between 1.4–1.7 for mission-critical computing.
- Enables initial deployment of 2,000+ GPUs (expandable to 4,000+ GPUs), supporting AI-as-a-Service, GPU compute marketplaces, application-specific inference, and high-performance computing offerings.
14 hours ago
Celcuity presents updated VIKTORIA-1 wild-type cohort results
NDAQ
- For patients with >18-month time to progression on prior therapy, median PFS was 12.4 months with the gedatolisib triplet and 10.0 months with the gedatolisib doublet versus 1.9 months for fulvestrant.
- In patients enrolled in the U.S., Canada, Western Europe, and Asia Pacific, median PFS reached 16.6 months with the triplet and 7.1 months with the doublet versus 1.9 months for fulvestrant.
- Stomatitis mitigation was generally effective, with median time to improvement to a lower grade ranging from 8 to 14 days across the two regimens.
- Quality-of-life measures showed the triplet delayed definitive deterioration to 23.7 months (not reached for the doublet) versus 4.0 months for fulvestrant.
15 hours ago
SEGG Media closes $2.5 million funding agreement
NDAQ
New Projects/Investments
M&A
- SEGG Media closed a $2.5 million Securities Purchase Agreement under its S-3 shelf registration, effective November 28, 2025.
- The proceeds will support a $5 million, 90-day plan of key initiatives, beginning with acquiring a controlling interest in Veloce Media Group, valued at $53 million pre-money.
- The plan also covers funding the DotCom Ventures acquisition, expanding gaming operations in Mexico, and developing the Boca Raton Sports.com arena.
- SEGG projects the Veloce acquisition alone will contribute approximately $20 million in annual revenue starting in Q1 2026, exceeding its total top line since its 2021 IPO.
19 hours ago
Oxbridge Re partners with Alphaledger to bring tokenized reinsurance to Solana
NDAQ
Product Launch
- Oxbridge Re subsidiary SurancePlus joins Alphaledger to deploy tokenized reinsurance securities on Solana via the Vulcan Forge infrastructure.
- The offerings include balanced-yield and high-yield RWA products targeting 20% and 42% annual returns, with current on-track performance at 25% and 42%, respectively, all unleveraged.
- Participation requires a minimum $5,000 investment for eligible Reg D and Reg S investors, broadening access beyond traditional institutional channels.
- Positions Oxbridge Re as the first publicly traded company to tokenize reinsurance contracts, aiming to accelerate institutional-grade RWA adoption in the Solana ecosystem.
20 hours ago
Nasdaq Private Market announces partnership with Cerity Partners
NDAQ
New Projects/Investments
- Cerity Partners makes a strategic investment in Nasdaq Private Market, gaining sole access to NPM’s liquidity program clients to deliver integrated financial solutions.
- Employee shareholders have liquidated nearly $15 billion through NPM-facilitated secondary liquidity programs in 2025, underscoring the scale of private equity transactions.
- Since inception, NPM has executed $70 billion in transactional volume across 775+ company-sponsored liquidity programs for over 200,000 participants, highlighting its market leadership.
- The alliance will combine NPM’s structured liquidity offerings with Cerity Partners’ advisory, tax, and equity compensation expertise to enhance the private company employee experience.
21 hours ago
Heartflow reports prognostic and economic benefits of FFRCT Analysis
NDAQ
- Real-world analysis of 90,553 NHS patients across 27 sites shows Heartflow FFRCT Analysis improves diagnostic decision-making and reduces avoidable tests.
- Lesion-specific FFRCT values correlate with outcomes, with patients in the lowest tier facing a 4-fold increase in myocardial infarction risk and a 3-fold increase in cardiovascular death.
- Integration of FFRCT into the diagnostic pathway produced £1,042 GBP ($1,394 USD) in per-patient savings over two years, suggesting £25 million GBP in annual NHS cost savings.
- Findings were presented at the European Association of Cardiovascular Imaging conference in 2025, reinforcing the clinical and economic value of Heartflow’s AI-powered platform.
1 day ago
Zealand Pharma unveils Metabolic Frontier 2030 strategy
NDAQ
New Projects/Investments
- Zealand Pharma targets five launches, 10+ clinical pipeline programs and industry-leading cycle times from idea to clinic by 2030 as part of its Metabolic Frontier 2030 strategy.
- Plans a catalyst-rich 2026, including Phase 2 data with petrelintide in Q1 2026 and Phase 3 obesity data for survodutide throughout 2026.
- Establishing a new research site in Boston to leverage over 25 years of peptide expertise with AI-driven drug discovery and advanced automation.
- Advancing oral small-molecule receptor agonists through a collaboration with OTR Therapeutics to expand its metabolic health pipeline.
1 day ago
Quarterly earnings call transcripts for NASDAQ.
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more